Edition:
United Kingdom

NantHealth Inc (NH.OQ)

NH.OQ on NASDAQ Stock Exchange Global Select Market

1.55USD
21 Sep 2018
Change (% chg)

$-0.01 (-0.64%)
Prev Close
$1.56
Open
$1.55
Day's High
$1.60
Day's Low
$1.48
Volume
349,394
Avg. Vol
32,474
52-wk High
$5.25
52-wk Low
$1.31

Latest Key Developments (Source: Significant Developments)

Nanthealth Inc - Co Appointed Bob Petrou As Interim Chief Financial Officer
Wednesday, 12 Sep 2018 

Sept 12 (Reuters) - NantHealth Inc ::NANTHEALTH INC SAYS ON SEPTEMBER 6, CO APPOINTED BOB PETROU AS INTERIM CHIEF FINANCIAL OFFICER, EFFECTIVE AS OF SEPTEMBER 12.  Full Article

Nanthealth Inc Says CFO Paul Holt To Resign, Effective Sept. 11, 2018 - SEC Filing
Thursday, 23 Aug 2018 

Aug 23 (Reuters) - NantHealth Inc ::NANTHEALTH INC SAYS ON AUGUST 19, PAUL HOLT, CFO, NOTIFIED CO OF HIS INTENTION TO RESIGN, EFFECTIVE AS OF SEPTEMBER 11, 2018 - SEC FILING.NANTHEALTH INC - BOARD IS IN THE PROCESS OF SELECTING AN INTERIM CFO UPON EFFECTIVE DATE OF HOLT'S RESIGNATION.  Full Article

NantHealth reports 2017 third quarter financial results
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Nanthealth Inc :NantHealth reports 2017 third quarter financial results; GPS revenue doubles from preceding quarter.Q3 adjusted non-GAAP loss per share $0.13 from continuing operations.Q3 loss per share $0.20 from continuing operations.Q3 loss per share $0.37.Q3 revenue $21.8 million versus $20.7 million.Q3 revenue view $29.2 million -- Thomson Reuters I/B/E/S.Q3 earnings per share view $-0.13 -- Thomson Reuters I/B/E/S.NantHealth Inc - ‍ restructuring plan was initiated in Q3, plan expected to generate annualized cost savings of more than $70 million​.  Full Article

Photo

Biotech's Soon-Shiong hiring bankers for Nant cancer drug IPO

LOS ANGELES Billionaire Patrick Soon-Shiong plans to take an experimental cancer treatment company public this year and has begun hiring bankers, the biotechnology entrepreneur told Reuters.